Annual Current Liabilities
$9.49 M
-$14.89 M-61.08%
December 31, 2023
Summary
- As of February 12, 2025, MREO annual total current liabilities is $9.49 million, with the most recent change of -$14.89 million (-61.08%) on December 31, 2023.
- During the last 3 years, MREO annual current liabilities has fallen by -$2.19 million (-18.73%).
- MREO annual current liabilities is now -75.79% below its all-time high of $39.17 million, reached on December 31, 2019.
Performance
MREO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$14.21 M
-$1.26 M-8.13%
September 30, 2024
Summary
- As of February 12, 2025, MREO quarterly total current liabilities is $14.21 million, with the most recent change of -$1.26 million (-8.13%) on September 30, 2024.
- Over the past year, MREO quarterly current liabilities has dropped by -$1.26 million (-8.13%).
- MREO quarterly current liabilities is now -66.73% below its all-time high of $42.70 million, reached on June 30, 2022.
Performance
MREO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MREO Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -61.1% | -8.1% |
3 y3 years | -18.7% | -16.1% |
5 y5 years | -53.8% | +21.7% |
MREO Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -61.1% | at low | -66.7% | +49.8% |
5 y | 5-year | -75.8% | at low | -66.7% | +49.8% |
alltime | all time | -75.8% | +139.6% | -66.7% | +258.8% |
Mereo BioPharma Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $14.21 M(-8.1%) |
Jun 2024 | - | $15.47 M(+40.5%) |
Mar 2024 | - | $11.00 M(+16.0%) |
Dec 2023 | $9.49 M(-61.1%) | $9.49 M(-56.9%) |
Jun 2023 | - | $22.02 M(-9.7%) |
Dec 2022 | $24.38 M(+44.0%) | $24.38 M(-42.9%) |
Jun 2022 | - | $42.70 M(+152.3%) |
Dec 2021 | $16.93 M(+45.0%) | $16.93 M(+23.9%) |
Jun 2021 | - | $13.66 M(+17.1%) |
Dec 2020 | $11.67 M | $11.67 M(-57.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2020 | - | $27.53 M(-29.7%) |
Dec 2019 | $39.17 M(+90.8%) | $39.17 M(+46.8%) |
Jun 2019 | - | $26.69 M(+30.0%) |
Dec 2018 | $20.53 M(+57.9%) | $20.53 M(+11.0%) |
Jun 2018 | - | $18.49 M(+42.3%) |
Dec 2017 | $13.00 M(+228.3%) | $13.00 M(-16.3%) |
Jun 2017 | - | $15.52 M(+292.0%) |
Dec 2016 | $3.96 M(-32.8%) | $3.96 M(-49.0%) |
Jun 2016 | - | $7.76 M(+31.7%) |
Dec 2015 | $5.89 M | $5.89 M |
FAQ
- What is Mereo BioPharma annual total current liabilities?
- What is the all time high annual current liabilities for Mereo BioPharma?
- What is Mereo BioPharma annual current liabilities year-on-year change?
- What is Mereo BioPharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Mereo BioPharma?
- What is Mereo BioPharma quarterly current liabilities year-on-year change?
What is Mereo BioPharma annual total current liabilities?
The current annual current liabilities of MREO is $9.49 M
What is the all time high annual current liabilities for Mereo BioPharma?
Mereo BioPharma all-time high annual total current liabilities is $39.17 M
What is Mereo BioPharma annual current liabilities year-on-year change?
Over the past year, MREO annual total current liabilities has changed by -$14.89 M (-61.08%)
What is Mereo BioPharma quarterly total current liabilities?
The current quarterly current liabilities of MREO is $14.21 M
What is the all time high quarterly current liabilities for Mereo BioPharma?
Mereo BioPharma all-time high quarterly total current liabilities is $42.70 M
What is Mereo BioPharma quarterly current liabilities year-on-year change?
Over the past year, MREO quarterly total current liabilities has changed by -$1.26 M (-8.13%)